Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Receivables - Other (2023 - 2024)

Historic Receivables - Other for Bolt Biotherapeutics (BOLT) over the last 2 years, with Q4 2024 value amounting to $1.2 million.

  • Bolt Biotherapeutics' Receivables - Other fell 2370.66% to $1.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.2 million, marking a year-over-year decrease of 2370.66%. This contributed to the annual value of $1.2 million for FY2024, which is 2370.66% down from last year.
  • Per Bolt Biotherapeutics' latest filing, its Receivables - Other stood at $1.2 million for Q4 2024, which was down 2370.66% from $1.5 million recorded in Q4 2023.
  • In the past 5 years, Bolt Biotherapeutics' Receivables - Other registered a high of $1.5 million during Q4 2023, and its lowest value of $1.2 million during Q4 2024.